ATE535257T1 - Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin - Google Patents
Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacinInfo
- Publication number
- ATE535257T1 ATE535257T1 AT06787575T AT06787575T ATE535257T1 AT E535257 T1 ATE535257 T1 AT E535257T1 AT 06787575 T AT06787575 T AT 06787575T AT 06787575 T AT06787575 T AT 06787575T AT E535257 T1 ATE535257 T1 AT E535257T1
- Authority
- AT
- Austria
- Prior art keywords
- formulation
- methylsulfonylmethane
- ciprofloxacin
- treatment
- ophthalmological formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title 2
- 229960003405 ciprofloxacin Drugs 0.000 title 1
- 229940016409 methylsulfonylmethane Drugs 0.000 title 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/182,998 US20060172972A1 (en) | 2002-12-20 | 2005-07-15 | Formulation and method for administration of ophthalmologically active agents |
| US11/183,479 US20060177430A1 (en) | 2002-12-20 | 2005-07-15 | Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer |
| PCT/US2006/027685 WO2007011874A2 (en) | 2005-07-15 | 2006-07-14 | Formulation and method for administration of ophthalmologically active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE535257T1 true ATE535257T1 (de) | 2011-12-15 |
Family
ID=39996624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06787575T ATE535257T1 (de) | 2005-07-15 | 2006-07-14 | Ophthalmologische formulierung mit methylsulfonylmethan und ciprofloxacin |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060172972A1 (de) |
| JP (1) | JP2009501726A (de) |
| CN (1) | CN101262886A (de) |
| AT (1) | ATE535257T1 (de) |
| EA (1) | EA200800337A1 (de) |
| IL (1) | IL188789A0 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200800338A1 (ru) * | 2005-07-15 | 2008-08-29 | Чакшу Рисерч Инк. | Профилактика и лечение офтальмологических осложнений диабета |
| EP2178502A2 (de) * | 2007-06-21 | 2010-04-28 | Yale University | Verzögerte abgabe von arzneimitteln aus biologisch abbaubaren polymer-mikroteilchen |
| US9616127B2 (en) * | 2008-03-11 | 2017-04-11 | Livionex Inc. | Method and topical formulation for treating localized edema |
| US10463677B2 (en) * | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
| US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US20100298335A1 (en) * | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and Methods for Ameliorating or Reducing Presbyopia |
| SI3708178T1 (sl) | 2009-08-24 | 2024-01-31 | Stealth Biotherapeutics Inc. | Peptid za uporabo pri preprečevanju ali zdravljenju degeneracije makule |
| KR20120095371A (ko) * | 2009-10-01 | 2012-08-28 | 에보닉 데구사 코포레이션 | 노화 황반변성 치료용 극미립자 조성물들 및 노화 황반변성 치료방법 |
| JP5956992B2 (ja) * | 2010-08-17 | 2016-07-27 | オーエイチアール・ファーマシューティカル・インコーポレイテッドOhr Pharmaceutical,Inc. | スクアラミンの眼用製剤 |
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| EP2694048B1 (de) * | 2011-04-05 | 2020-10-07 | Optosolve Research & Development Ltd | Augenbehandlungen |
| US9566301B2 (en) | 2012-03-29 | 2017-02-14 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| EP2830554A1 (de) | 2012-03-29 | 2015-02-04 | CXL Ophthalmics, LLC | Okulares vernetzungssystem und verfahren zum verschliessen von wunden in der augenhornhaut |
| EP4420725A3 (de) | 2012-03-29 | 2025-04-16 | Epion Therapeutics, Inc. | Augenbehandlungslösungen, abgabevorrichtungen und abgabeverstärkungsverfahren |
| US10507245B2 (en) | 2012-07-19 | 2019-12-17 | Luis Felipe Vejarano Restrepo | Ophthalmic formulation and method for ameliorating presbyopia |
| CA2934448A1 (en) * | 2012-12-20 | 2014-06-26 | Rajiv Bhushan | Antimicrobial compositions |
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US11179327B2 (en) * | 2013-08-28 | 2021-11-23 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
| US9089562B2 (en) * | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| WO2016068278A1 (ja) * | 2014-10-31 | 2016-05-06 | 学校法人慶應義塾 | 水晶体硬化抑制剤 |
| US12653779B2 (en) | 2015-06-18 | 2026-06-16 | Lenz Therapeutics Operations, Inc. | Compositions and methods for the treatment of presbyopia |
| WO2017083800A1 (en) * | 2015-11-13 | 2017-05-18 | Ohr Pharmaceutical, Inc. | Occult cnv size as a predictor for treatment with squalamine |
| JP2021512847A (ja) * | 2018-02-05 | 2021-05-20 | リビオネックス・インコーポレイテッドLivionex, Inc. | キレート剤、浸透促進剤およびヒドロキシエチルセルロースを含む眼科疾患治療用製剤 |
| CN109091675B (zh) * | 2018-08-31 | 2021-09-17 | 杭州赫尔斯科技有限公司 | 一种复方低浓度阿托品类药物滴眼液及其制备方法 |
| US20210251970A1 (en) | 2018-10-10 | 2021-08-19 | Presbyopia Therapies Inc | Compositions and methods for storage stable ophthalmic drugs |
| JP2022511051A (ja) * | 2018-12-05 | 2022-01-28 | レンズ・セラピューティクス・インコーポレイテッド | キヌクリジン環含有ムスカリン性アゴニストのプロドラッグ及びその組成物ならびに方法 |
| CN112823784B (zh) * | 2019-11-20 | 2022-09-16 | 湖北远大天天明制药有限公司 | 吡诺克辛钠滴眼液以及用于眼部给药的溶液 |
| WO2023091439A1 (en) | 2021-11-17 | 2023-05-25 | Lenz Therapeutics, Inc. | Aceclidine derivatives, compositions thereof and methods of use thereof |
| US20230310380A1 (en) * | 2022-04-05 | 2023-10-05 | Alan Neil Glazier | Methods, devices, and systems for treating lens protein aggregation diseases |
| US12414942B1 (en) | 2024-03-15 | 2025-09-16 | Lenz Therapeutics Operations, Inc. | Compositions, methods, and systems for treating presbyopia |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
| US4087538A (en) * | 1976-09-09 | 1978-05-02 | Merck & Co., Inc. | Ophthalmic suspensions |
| US4294853A (en) * | 1979-06-13 | 1981-10-13 | Abbott Laboratories | Biocidal additive for cutting fluids |
| US4863748A (en) * | 1979-08-30 | 1989-09-05 | Herschler R J | Dietary products and uses comprising methylsulfonylmethane |
| US4390542A (en) * | 1980-12-02 | 1983-06-28 | Schachar Ronald A | Method for inhibiting contraction of opthalmic wounds or incisions |
| US4510145A (en) * | 1980-12-02 | 1985-04-09 | Schachar Ronald A | Method for inhibiting contraction of ophthalmic wounds or incisions |
| FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| US5032392A (en) * | 1986-09-04 | 1991-07-16 | Vision Pharmaceuticals | Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes |
| US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
| US4923693A (en) * | 1988-01-21 | 1990-05-08 | Sundrops Enterprises, Inc. | Ultraviolet radiation screening method for eyes |
| US5360611A (en) * | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
| US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5278142A (en) * | 1989-03-20 | 1994-01-11 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5221696A (en) * | 1989-03-29 | 1993-06-22 | Alcon Laboratories, Inc. | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
| US5660851A (en) * | 1989-12-26 | 1997-08-26 | Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem | Ocular inserts |
| US5300295A (en) * | 1990-05-01 | 1994-04-05 | Mediventures, Inc. | Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
| US5525601A (en) * | 1990-09-07 | 1996-06-11 | Universidad De Alicante | Composition for treating ocular pain |
| CA2117199C (en) * | 1991-09-09 | 2004-12-28 | Jurgen Michaelis | Method for the treatment of the complications and pathology of diabetes |
| ZA927277B (en) * | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
| US5270051A (en) * | 1991-10-15 | 1993-12-14 | Harris Donald H | Enzyme-orthokeratology |
| US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| US6015834A (en) * | 1992-10-20 | 2000-01-18 | Toronto Neuroprotection Group | In vivo treatment of mammalian cells with a cell membrane permeant calcium buffer |
| US5443505A (en) * | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| DE69434617D1 (de) * | 1993-11-19 | 2006-04-06 | Univ Sydney | Verfahren zur prophylaxe oder kontrolle des katarakts |
| US5443824A (en) * | 1994-03-14 | 1995-08-22 | Piacquadio; Daniel J. | Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions |
| AU2829395A (en) * | 1994-06-16 | 1996-01-05 | Allergan, Inc. | Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators |
| NO315930B1 (no) * | 1995-01-18 | 2003-11-17 | Picower Inst For Medical Res T | Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser |
| EP0808163B1 (de) * | 1995-01-18 | 2003-07-23 | Alteon, Inc. | Verwendung von thiazoliumverbindungen zum verhindern und umkehren der bildung von endprodukten der fortgeschrittenen glykosylierung |
| US5824685A (en) * | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| NZ335042A (en) * | 1996-10-14 | 2001-01-26 | Kissei Pharmaceutical | Tranilast (N-(3,4-dimethoxycinnamoyl)anthranilic acid) as a secondary cataract inhibitor |
| US6410046B1 (en) * | 1996-11-19 | 2002-06-25 | Intrabrain International Nv | Administering pharmaceuticals to the mammalian central nervous system |
| MX9701946A (es) * | 1997-03-14 | 1998-04-30 | Arturo Jimenez Bayardo | Solucion oftalmica transportadora. |
| US5817630A (en) * | 1997-03-18 | 1998-10-06 | Austin Nutriceutical Corporation | Glutathione antioxidant eye drops |
| ATE246489T1 (de) * | 1997-03-31 | 2003-08-15 | Alza Corp | Implantierbares diffusionabgabesystem |
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6265444B1 (en) * | 1997-05-23 | 2001-07-24 | Insite Vision Incorporated | Ophthalmic composition |
| US6159458A (en) * | 1997-11-04 | 2000-12-12 | Insite Vision | Sustained release ophthalmic compositions containing water soluble medicaments |
| US6555522B1 (en) * | 1998-02-05 | 2003-04-29 | Mount Sinai School Of Medicine Of The City Of New York | Peptides and other small molecules derived from regions of interacting proteins and uses thereof |
| US6197934B1 (en) * | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| US6211238B1 (en) * | 1998-10-27 | 2001-04-03 | Alcon Laboratories, Inc. | Preservative system for topically administrable pharmaceutical compositions |
| US6171337B1 (en) * | 1999-03-31 | 2001-01-09 | Miles A. Galin | Positive power anterior chamber ocular implant |
| AU763750B2 (en) * | 1999-04-05 | 2003-07-31 | City Of Hope | Novel inhibitors of formation of advanced glycation endproducts (AGE's) |
| US6548059B1 (en) * | 1999-07-22 | 2003-04-15 | The Schepens Eye Research Institute, Inc. | Promotion of proliferation of adult corneal endothelial cells |
| WO2001013956A2 (en) * | 1999-08-26 | 2001-03-01 | Ganeden Biotech, Inc. | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
| US6653352B2 (en) * | 1999-09-29 | 2003-11-25 | Medical Merchandising, Inc. | Pain reliever and method of use |
| CA2385703A1 (en) * | 1999-10-07 | 2001-04-12 | Human Genome Sciences, Inc. | Plasminogen-like polynucleotides, polypeptides, and antibodies |
| US6331313B1 (en) * | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6348508B1 (en) * | 2000-04-04 | 2002-02-19 | Bausch & Lomb Incorporated | Method for treating dry eye |
| RU2165749C1 (ru) * | 2000-07-06 | 2001-04-27 | Общество с ограниченной ответственностью "Научно-экспериментальное производство Микрохирургия глаза" | Способ восстановления эндотелия роговицы |
| US6572849B2 (en) * | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
| US6328987B1 (en) * | 2000-11-03 | 2001-12-11 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions containing alpha interferon |
| US7084130B2 (en) * | 2001-12-11 | 2006-08-01 | Alcon, Inc. | Intraocular irrigating solution having improved flow characteristics |
| US6713081B2 (en) * | 2001-03-15 | 2004-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Ocular therapeutic agent delivery devices and methods for making and using such devices |
| US6533769B2 (en) * | 2001-05-03 | 2003-03-18 | Holmen Joergen | Method for use in cataract surgery |
| US20030065292A1 (en) * | 2001-06-08 | 2003-04-03 | Darouiche Rabih O. | Ozonated medical devices and methods of using ozone to prevent complications from indwelling medical devices |
| US20030083286A1 (en) * | 2001-08-22 | 2003-05-01 | Ching-Leou Teng | Bioadhesive compositions and methods for enhanced intestinal drug absorption |
| ATE507816T1 (de) * | 2001-11-14 | 2011-05-15 | Durect Corp | Injizierbare depotzusammensetzungen und deren verwendung |
| US20030114460A1 (en) * | 2001-12-14 | 2003-06-19 | Allergan Sales, Inc. | Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| WO2004058289A1 (en) * | 2002-12-20 | 2004-07-15 | Chakshu Research, Inc. | Ophthalmic formulation for the prevention and treatment of ocular conditions |
-
2005
- 2005-07-15 US US11/182,998 patent/US20060172972A1/en not_active Abandoned
-
2006
- 2006-07-14 CN CNA2006800339508A patent/CN101262886A/zh active Pending
- 2006-07-14 EA EA200800337A patent/EA200800337A1/ru unknown
- 2006-07-14 AT AT06787575T patent/ATE535257T1/de active
- 2006-07-14 JP JP2008521703A patent/JP2009501726A/ja active Pending
-
2008
- 2008-01-15 IL IL188789A patent/IL188789A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200800337A1 (ru) | 2008-08-29 |
| CN101262886A (zh) | 2008-09-10 |
| US20060172972A1 (en) | 2006-08-03 |
| IL188789A0 (en) | 2008-12-29 |
| JP2009501726A (ja) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188789A0 (en) | Formulation and method for administration of ophthalmologically active agents | |
| WO2007011874A3 (en) | Formulation and method for administration of ophthalmologically active agents | |
| EP2322219A3 (de) | Verwendung von IL-23- und IL-17-Antagonisten zur Behandlung von Augenentzündungsautoimmunerkrankungen | |
| WO2019209962A8 (en) | Compounds and uses thereof | |
| NO20075660L (no) | Blanding for behandling av inflammatoriske sykdommer | |
| DE602006006308D1 (de) | Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten | |
| WO2019209948A8 (en) | Compounds and uses thereof | |
| MX2007005570A (es) | Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos. | |
| WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
| DE602007012236D1 (de) | Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil | |
| CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
| BRPI0607483A2 (pt) | microimplantes para administração ocular | |
| DE602004032522D1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
| CY1112981T1 (el) | Μεθοδος και συνθεση για την αγωγη της ρινιτιδας | |
| HK1198869A1 (en) | Combination treatments for hepatitis c | |
| WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| DK1864668T3 (da) | Anvendelse af prodrug til okulær, intravitreal administration | |
| WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
| WO2007077203A3 (en) | Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases | |
| ATE477805T1 (de) | 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität | |
| ATE495735T1 (de) | Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden | |
| WO2017152129A3 (en) | Treatment of glaucoma and/or retinal diseases and formulations useful therefore | |
| WO2021247916A8 (en) | Azetidine and spiroazetidine compounds and uses thereof | |
| WO2021247921A8 (en) | Benzothiazole compounds and uses thereof | |
| WO2009061445A3 (en) | Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |